Syntal Capital Partners’s Elevance Health ELV Stock Holding History

Syntal Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-127	Closed	-$17K	–	93
2015 Q3	$17K	Hold	127	–	–	0.02%	120
2015 Q2	$20K	Buy	+127	New	+$20.3K	0.02%	133
2014 Q4	–	Sell	-168	Closed	-$20K	–	175
2014 Q3	$20K	Hold	168	–	–	0.01%	161
2014 Q2	$18K	Hold	168	–	–	0.01%	175
2014 Q1	$16K	Buy	+168	New	+$15.2K	0.01%	112

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Syntal Capital Partners's ELV Position: Q4 2015 in Review

Syntal Capital Partners sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 127 shares — an estimated $17K sold.

Syntal Capital Partners first reported a position in ELV in Q1 2014 and held it in 5 quarters. The position peaked at $20K in Q2 2015. 766 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Syntal Capital Partners reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
Syntal Capital Partners sold 127 Elevance Health shares in Q4 2015, an estimated $17K.
Syntal Capital Partners first reported a position in Elevance Health in Q1 2014 and held it in 5 quarters.
Syntal Capital Partners's Elevance Health position peaked at $20K in Q2 2015.
766 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Syntal Capital Partners's 13F filing for Q4 2015, filed 12 Feb 2016.